nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Gadoxetate—SLCO1B1—breast cancer	0.0114	1	CrCbGaD
Gadoversetamide—Pharyngitis—Doxorubicin—breast cancer	0.000183	0.000185	CcSEcCtD
Gadoversetamide—Paraesthesia—Capecitabine—breast cancer	0.000182	0.000185	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—breast cancer	0.000182	0.000185	CcSEcCtD
Gadoversetamide—Hypersensitivity—Paclitaxel—breast cancer	0.000182	0.000185	CcSEcCtD
Gadoversetamide—Headache—Fluorouracil—breast cancer	0.000182	0.000184	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—breast cancer	0.000182	0.000184	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—breast cancer	0.000182	0.000184	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—breast cancer	0.000182	0.000184	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—breast cancer	0.000181	0.000183	CcSEcCtD
Gadoversetamide—Dyspnoea—Capecitabine—breast cancer	0.000181	0.000183	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—breast cancer	0.000181	0.000183	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—breast cancer	0.000181	0.000183	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—breast cancer	0.000181	0.000183	CcSEcCtD
Gadoversetamide—Nausea—Irinotecan—breast cancer	0.00018	0.000182	CcSEcCtD
Gadoversetamide—Nausea—Mitoxantrone—breast cancer	0.00018	0.000182	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—breast cancer	0.00018	0.000182	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—breast cancer	0.00018	0.000182	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—breast cancer	0.000179	0.000182	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—breast cancer	0.000179	0.000182	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—breast cancer	0.000179	0.000181	CcSEcCtD
Gadoversetamide—Dyspepsia—Capecitabine—breast cancer	0.000179	0.000181	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—breast cancer	0.000179	0.000181	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—breast cancer	0.000178	0.00018	CcSEcCtD
Gadoversetamide—Asthenia—Paclitaxel—breast cancer	0.000178	0.00018	CcSEcCtD
Gadoversetamide—Decreased appetite—Capecitabine—breast cancer	0.000177	0.000179	CcSEcCtD
Gadoversetamide—Nausea—Gemcitabine—breast cancer	0.000176	0.000178	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Capecitabine—breast cancer	0.000175	0.000177	CcSEcCtD
Gadoversetamide—Fatigue—Capecitabine—breast cancer	0.000175	0.000177	CcSEcCtD
Gadoversetamide—Pruritus—Paclitaxel—breast cancer	0.000175	0.000177	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—breast cancer	0.000175	0.000177	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—breast cancer	0.000175	0.000177	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—breast cancer	0.000174	0.000176	CcSEcCtD
Gadoversetamide—Pain—Capecitabine—breast cancer	0.000174	0.000176	CcSEcCtD
Gadoversetamide—Constipation—Capecitabine—breast cancer	0.000174	0.000176	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—breast cancer	0.000173	0.000175	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—breast cancer	0.000173	0.000175	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—breast cancer	0.000173	0.000175	CcSEcCtD
Gadoversetamide—Nausea—Fluorouracil—breast cancer	0.000173	0.000175	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—breast cancer	0.000172	0.000174	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—breast cancer	0.000172	0.000174	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—breast cancer	0.000172	0.000174	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—breast cancer	0.000172	0.000174	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—breast cancer	0.000171	0.000173	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—breast cancer	0.000171	0.000173	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—breast cancer	0.000171	0.000173	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—breast cancer	0.00017	0.000172	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—breast cancer	0.00017	0.000172	CcSEcCtD
Gadoversetamide—Diarrhoea—Paclitaxel—breast cancer	0.000169	0.000171	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—breast cancer	0.000168	0.00017	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—breast cancer	0.000168	0.00017	CcSEcCtD
Gadoversetamide—Feeling abnormal—Capecitabine—breast cancer	0.000167	0.000169	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—breast cancer	0.000167	0.000169	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—breast cancer	0.000167	0.000169	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—breast cancer	0.000167	0.000169	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—breast cancer	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—breast cancer	0.000167	0.000168	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Capecitabine—breast cancer	0.000166	0.000168	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—breast cancer	0.000166	0.000168	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—breast cancer	0.000166	0.000168	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—breast cancer	0.000166	0.000168	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—breast cancer	0.000165	0.000167	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—breast cancer	0.000165	0.000167	CcSEcCtD
Gadoversetamide—Dizziness—Paclitaxel—breast cancer	0.000164	0.000166	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—breast cancer	0.000163	0.000165	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—breast cancer	0.000162	0.000164	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—breast cancer	0.000162	0.000163	CcSEcCtD
Gadoversetamide—Urticaria—Capecitabine—breast cancer	0.000161	0.000163	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—breast cancer	0.000161	0.000163	CcSEcCtD
Gadoversetamide—Abdominal pain—Capecitabine—breast cancer	0.000161	0.000163	CcSEcCtD
Gadoversetamide—Body temperature increased—Capecitabine—breast cancer	0.000161	0.000163	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—breast cancer	0.000161	0.000162	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—breast cancer	0.000161	0.000162	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—breast cancer	0.000161	0.000162	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—breast cancer	0.000159	0.000161	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—breast cancer	0.000158	0.00016	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—breast cancer	0.000158	0.00016	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—breast cancer	0.000158	0.00016	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—breast cancer	0.000158	0.00016	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—breast cancer	0.000158	0.000159	CcSEcCtD
Gadoversetamide—Vomiting—Paclitaxel—breast cancer	0.000157	0.000159	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—breast cancer	0.000157	0.000159	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000157	0.000159	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Rash—Paclitaxel—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Dermatitis—Paclitaxel—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—breast cancer	0.000156	0.000158	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—breast cancer	0.000156	0.000157	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—breast cancer	0.000155	0.000157	CcSEcCtD
Gadoversetamide—Headache—Paclitaxel—breast cancer	0.000155	0.000157	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—breast cancer	0.000155	0.000156	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—breast cancer	0.000154	0.000156	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—breast cancer	0.000153	0.000155	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—breast cancer	0.000153	0.000154	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—breast cancer	0.000152	0.000154	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—breast cancer	0.000151	0.000153	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—breast cancer	0.000151	0.000153	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—breast cancer	0.000151	0.000153	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—breast cancer	0.000151	0.000152	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—breast cancer	0.00015	0.000152	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—breast cancer	0.00015	0.000152	CcSEcCtD
Gadoversetamide—Hypersensitivity—Capecitabine—breast cancer	0.00015	0.000151	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—breast cancer	0.000149	0.000151	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—breast cancer	0.000149	0.00015	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—breast cancer	0.000148	0.00015	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—breast cancer	0.000148	0.00015	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—breast cancer	0.000148	0.000149	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—breast cancer	0.000147	0.000149	CcSEcCtD
Gadoversetamide—Nausea—Paclitaxel—breast cancer	0.000147	0.000149	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—breast cancer	0.000147	0.000149	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000147	0.000148	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—breast cancer	0.000146	0.000148	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—breast cancer	0.000146	0.000148	CcSEcCtD
Gadoversetamide—Asthenia—Capecitabine—breast cancer	0.000146	0.000147	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—breast cancer	0.000145	0.000146	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—breast cancer	0.000144	0.000146	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—breast cancer	0.000144	0.000146	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—breast cancer	0.000144	0.000146	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—breast cancer	0.000144	0.000146	CcSEcCtD
Gadoversetamide—Pruritus—Capecitabine—breast cancer	0.000144	0.000145	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—breast cancer	0.000144	0.000145	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—breast cancer	0.000143	0.000144	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—breast cancer	0.000142	0.000143	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—breast cancer	0.000142	0.000143	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—breast cancer	0.000142	0.000143	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—breast cancer	0.000141	0.000143	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—breast cancer	0.000141	0.000143	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—breast cancer	0.00014	0.000142	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—breast cancer	0.000139	0.000141	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—breast cancer	0.000139	0.000141	CcSEcCtD
Gadoversetamide—Diarrhoea—Capecitabine—breast cancer	0.000139	0.000141	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—breast cancer	0.000139	0.00014	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—breast cancer	0.000139	0.00014	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—breast cancer	0.000139	0.00014	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—breast cancer	0.000139	0.00014	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—breast cancer	0.000138	0.00014	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000138	0.000139	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—breast cancer	0.000138	0.000139	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—breast cancer	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—breast cancer	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—breast cancer	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—breast cancer	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—breast cancer	0.000137	0.000138	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—breast cancer	0.000136	0.000138	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—breast cancer	0.000136	0.000137	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000136	0.000137	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—breast cancer	0.000135	0.000137	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—breast cancer	0.000135	0.000137	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—breast cancer	0.000135	0.000136	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—breast cancer	0.000134	0.000136	CcSEcCtD
Gadoversetamide—Dizziness—Capecitabine—breast cancer	0.000134	0.000136	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—breast cancer	0.000134	0.000135	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—breast cancer	0.000133	0.000135	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—breast cancer	0.000133	0.000135	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—breast cancer	0.000132	0.000134	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—breast cancer	0.000132	0.000134	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—breast cancer	0.000132	0.000134	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—breast cancer	0.000132	0.000134	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—breast cancer	0.000132	0.000133	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—breast cancer	0.000131	0.000133	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—breast cancer	0.000131	0.000133	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—breast cancer	0.000131	0.000133	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—breast cancer	0.000131	0.000132	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—breast cancer	0.00013	0.000132	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—breast cancer	0.000129	0.000131	CcSEcCtD
Gadoversetamide—Vomiting—Capecitabine—breast cancer	0.000129	0.000131	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000129	0.00013	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—breast cancer	0.000129	0.00013	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—breast cancer	0.000128	0.00013	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—breast cancer	0.000128	0.00013	CcSEcCtD
Gadoversetamide—Rash—Capecitabine—breast cancer	0.000128	0.00013	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—breast cancer	0.000128	0.00013	CcSEcCtD
Gadoversetamide—Dermatitis—Capecitabine—breast cancer	0.000128	0.000129	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—breast cancer	0.000128	0.000129	CcSEcCtD
Gadoversetamide—Headache—Capecitabine—breast cancer	0.000127	0.000129	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—breast cancer	0.000127	0.000129	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—breast cancer	0.000127	0.000129	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—breast cancer	0.000127	0.000128	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—breast cancer	0.000126	0.000128	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—breast cancer	0.000126	0.000127	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—breast cancer	0.000125	0.000126	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—breast cancer	0.000125	0.000126	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—breast cancer	0.000125	0.000126	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—breast cancer	0.000125	0.000126	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—breast cancer	0.000124	0.000125	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—breast cancer	0.000123	0.000124	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—breast cancer	0.000122	0.000124	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—breast cancer	0.000122	0.000124	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—breast cancer	0.000122	0.000123	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—breast cancer	0.000121	0.000122	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—breast cancer	0.000121	0.000122	CcSEcCtD
Gadoversetamide—Nausea—Capecitabine—breast cancer	0.000121	0.000122	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—breast cancer	0.00012	0.000122	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—breast cancer	0.00012	0.000121	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—breast cancer	0.00012	0.000121	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000119	0.000121	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—breast cancer	0.000118	0.00012	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—breast cancer	0.000118	0.000119	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—breast cancer	0.000117	0.000118	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—breast cancer	0.000117	0.000118	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—breast cancer	0.000116	0.000118	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—breast cancer	0.000116	0.000117	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—breast cancer	0.000115	0.000117	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—breast cancer	0.000114	0.000115	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000113	0.000114	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—breast cancer	0.000113	0.000114	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—breast cancer	0.000112	0.000114	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—breast cancer	0.000112	0.000113	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—breast cancer	0.000112	0.000113	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—breast cancer	0.000112	0.000113	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—breast cancer	0.000112	0.000113	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—breast cancer	0.000111	0.000113	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—breast cancer	0.000109	0.00011	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—breast cancer	0.000108	0.000109	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—breast cancer	0.000107	0.000108	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—breast cancer	0.000107	0.000108	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—breast cancer	0.000104	0.000106	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—breast cancer	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—breast cancer	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—breast cancer	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—breast cancer	0.000104	0.000105	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—breast cancer	0.000102	0.000103	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—breast cancer	0.0001	0.000101	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—breast cancer	0.0001	0.000101	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—breast cancer	9.69e-05	9.8e-05	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—breast cancer	9.65e-05	9.76e-05	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—breast cancer	9.62e-05	9.73e-05	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—breast cancer	9.54e-05	9.65e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—breast cancer	9.53e-05	9.64e-05	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—breast cancer	9.48e-05	9.59e-05	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—breast cancer	9.4e-05	9.51e-05	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—breast cancer	9.36e-05	9.47e-05	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—breast cancer	9.27e-05	9.38e-05	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—breast cancer	9e-05	9.11e-05	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—breast cancer	8.99e-05	9.09e-05	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—breast cancer	8.96e-05	9.07e-05	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—breast cancer	8.93e-05	9.03e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—breast cancer	8.92e-05	9.02e-05	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—breast cancer	8.87e-05	8.97e-05	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—breast cancer	8.66e-05	8.76e-05	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—breast cancer	8.41e-05	8.51e-05	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—breast cancer	8.33e-05	8.43e-05	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—breast cancer	8.26e-05	8.36e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—breast cancer	8.25e-05	8.35e-05	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—breast cancer	8.21e-05	8.3e-05	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—breast cancer	7.78e-05	7.87e-05	CcSEcCtD
